Skip to main content
Livermore
Livermore
ZHEN

Xponance, Inc.

SEC CIK
0001637541
Latest filing
Aug 10, 2026

RPRX holding history

Royalty Pharma plc in every 13F filed by Xponance, Inc., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.

RPRX overviewAll 13F holders of RPRXFull Q2 2026 holdings

Shares (Q2 2026)
55,752
Value
$3.13M
% of portfolio
<0.1%
Quarters held
22
Since Q1 2021
Holdings of RPRX by Xponance, Inc., by quarter
QuarterSharesValue% of portfolioShare changeActionAll holders
Q2 202655,752$3.13M<0.1%+3,105+5.9%AddedHolders
Q1 202652,647$2.53M<0.1%+7,978+17.9%AddedHolders
Q4 202544,669$1.73M<0.1%+3,415+8.3%AddedHolders
Q3 202541,254$1.46M<0.1%+331+0.8%AddedHolders
Q2 202540,923$1.47M<0.1%+790+2.0%AddedHolders
Q1 202540,133$1.25M<0.1%+1,437+3.7%AddedHolders
Q4 202438,696$987.1K<0.1%+5,402+16.2%AddedHolders
Q3 202433,294$941.9K<0.1%+1,590+5.0%AddedHolders
Q2 202431,704$836.0K<0.1%+606+1.9%AddedHolders
Q1 202431,098$944.4K<0.1%+17,583+130.1%AddedHolders
Q4 202313,515$379.6K<0.1%−4,703−25.8%ReducedHolders
Q3 202318,218$494.4K<0.1%+5,090+38.8%AddedHolders
Q2 202313,128$403.6K<0.1%−15−0.1%ReducedHolders
Q1 202313,143$473.5K<0.1%+63+0.5%AddedHolders
Q4 202213,080$516.9K<0.1%+5,972+84.0%AddedHolders
Q3 20227,108$286.0K<0.1%+153+2.2%AddedHolders
Q2 20226,955$292.0K<0.1%−16,442−70.3%ReducedHolders
Q1 202223,397$912.0K<0.1%+222+1.0%AddedHolders
Q4 202123,175$924.0K<0.1%+381+1.7%AddedHolders
Q3 202122,794$824.0K<0.1%−1,378−5.7%ReducedHolders
Q2 202124,172$991.0K<0.1%+9,793+68.1%AddedHolders
Q1 202114,379$627.0K<0.1%––Holders

Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.